IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$443M
AUM Growth
-$5.44M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
81
New
Increased
Reduced
Closed

Top Buys

1
+$11.8M
2
+$8.15M
3
+$6.61M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$6.34M
5
UTHR icon
United Therapeutics
UTHR
+$3.81M

Top Sells

1
+$17.9M
2
+$13.7M
3
+$12.4M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$12.4M
5
BIIB icon
Biogen
BIIB
+$11.4M

Sector Composition

1 Healthcare 99.23%
2 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$32.6M 7.34%
66,746
-78,000
2
$23.8M 5.38%
15,000
3
$21.7M 4.9%
38,000
-90,000
4
$20.9M 4.72%
50,956
-62,500
5
$20.5M 4.63%
205,474
-30,526
6
$19.3M 4.35%
+57,000
7
$18.5M 4.18%
+132,500
8
$17.9M 4.03%
63,000
9
$17.5M 3.94%
297,500
10
$17M 3.82%
78,958
+40,000
11
$14.3M 3.22%
40,100
-81,000
12
$11.8M 2.66%
155,500
13
$11.6M 2.62%
190,749
+70,214
14
$11.4M 2.57%
15,700
-4,300
15
$10.8M 2.44%
383,233
16
$10.8M 2.43%
49,344
+10,794
17
$10.1M 2.27%
68,000
18
$9.98M 2.25%
107,000
19
$9.29M 2.1%
130,900
-9,000
20
$8.68M 1.96%
14,093
-47,648
21
$8.19M 1.85%
38,000
+12,000
22
$7.65M 1.72%
+50,000
23
$7.64M 1.72%
+31,500
24
$7.45M 1.68%
183,473
+83,600
25
$5.92M 1.34%
17,200
-27,000
1
2 3 4